References
- Noor S, Zubair M, Ahmad J. Diabetic foot ulcer—a review on pathophysiology, classification and microbial etiology. Diabetes Metab Syndr. 2015; 9:192–9.
- Arshad M, Arshad S, Arshad S, Abbas H. The quality of life in patients with diabetic foot ulcers. J Diab Metab. 2020; 11:e101. doi: 10.35248/2155-6156.20.11.e101.
- Haghdoost A, Rezazadeh Kermani M, Sadghirad B, Baradaran H. Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis. Eastern Mediterr Health J. 2009: 15:591–9.
- Shafiee S, Raz A, Adibi N, Mansouri M, Annabestani Z, Mirzaeezadeh Z, et al. Assessment of the relationship between -1562C>T allele of MMP9 gene promoter with diabetic foot ulcer in type 2 diabetic patients referred to the clinic of diabetes & metabolic diseases. Iranian J Diabetes Metabol. 2018; 17:49–56. [in Persian; English title and abstract]
- Weledji EP, Fokam P. Treatment of the diabetic foot – to amputate or not? BMC Surg. 2014; 14:83. doi: 10.1186/1471-2482-14-83
- Cao Y, Gang X, Sun C, Wang G. Mesenchymal stem cells improve healing of diabetic foot ulcer. J Diabetes Res. 2017; 2017:9328347. doi: 10.1155/2017/9328347
- Guo J, Dardik A, Fang K, Huang R, Gu Y. Meta-analysis on the treatment of diabetic foot ulcers with autologous stem cells. Stem Cell Res Ther. 2017; 8:228. doi: 10.1186/s13287-017-0683-2
- Shu X, Shu S, Tang S, Yang L, Liu D, Li K, et al. Efficiency of stem cell based therapy in the treatment of diabetic foot ulcer: a meta-analysis. Endocr J. 2018; 65:403–13.
- Heublein H, Bader A, Giri S. Preclinical and clinical evidence for stem cell therapies as treatment for diabetic wounds. Drug Discov Today. 2015; 20:703–17.
- Meamar R, Nasr-Esfahani MH, Mousavi SA, Basiri K. Stem cell therapy in amyotrophic lateral sclerosis. J Clin Neurosci. 2013; 20:1659–63.
- Blumberg SN, Berger A, Hwang L, Pastar I, Warren SM, Chen W. The role of stem cells in the treatment of diabetic foot ulcers. Diabetes Res Clin Pract. 2012; 96:1–9.
- Ariyanti AD, Zhang J, Marcelina O, Nugrahaningrum DA, Wang G, Kasim V, Wu S. Salidroside-pretreated mesenchymal stem cells enhance diabetic wound healing by promoting paracrine function and survival of mesenchymal stem cells under hyperglycemia. Stem Cells Transl Med. 2019; 8:404–14.
- Holm JS, Toyserkani NM, Sorensen JA. Adipose-derived stem cells for treatment of chronic ulcers: current status. Stem Cell Res Ther. 2018; 9:142. doi: 10.1186/s13287-018-0887-0
- Qin HL, Zhu XH, Zhang B, Zhou L, Wang WY. Clinical evaluation of human umbilical cord mesenchymal stem cell transplantation after angioplasty for diabetic foot. Exp Clin Endocrinol Diabetes. 2016; 124:497–503.
- Davey GC, Patil SB, O’Loughlin A, O’Brien T. Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus. Front Endocrinol (Lausanne). 2014; 5:86. doi: 10.3389/fendo.2014.00086
- Ivanova NB, Dimos JT, Schaniel C, Hackney JA, Moore KA, Lemischka IR. A stem cell molecular signature. Science. 2002; 298(5593):601–4.
- Arwert EN, Hoste E, Watt FM. Epithelial stem cells, wound healing and cancer. Nature Rev Cancer. 2012; 12:170–80.
- Li Z, Hu X, Zhong JF. Mesenchymal stem cells: characteristics, function, and application. Stem Cells Int. 2019; 2019:8106818. doi: 10.1155/2019/8106818
- Banijamali RS, Soleimanjahi H, Soudi S, Karimi H, Abdoli A, Khorrami SMS, Zandi K. Kinetics of oncolytic reovirus T3D replication and growth pattern in mesenchymal stem cells. Cell J. 2020; 22:283–92.
- Dash NR, Dash SN, Routray P, Mohapatra S, Mohapatra PC. Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells. Rejuvenation Res. 2009; 12:359–66.
- Patel AN, Bartlett CE, Ichim TE. Mesenchymal Stem Cells. In: Perin EC, Miller LW, Taylor D, Willerson JT, editors. Stem cell and gene therapy for cardiovascular disease. Amsterdam: Elsevier Academic Press; 2016, p. 139–50.
- Kong P, Xie X, Li F, Liu Y, Lu Y. Placenta mesenchymal stem cell accelerates wound healing by enhancing angiogenesis in diabetic Goto-Kakizaki (GK) rats. Biochem Biophys Res Commun. 2013; 438:410–9.
- Wang Y, Dan Q, Wang Q, Zhou N, Jin X, Hou Z, et al. [Human umbilic mesenchymal stromal cells repairs diabetic foot in rats associated with VEGF expressional change]. Sichuan Da Xue Xue Bao Yi Xue Ban [J Sichuan Univ. Med Sci Edition]. 2014; 45:29–33. [article in Chinese, English Abstract]
- Son W-S, Park HJ, Lee C-J, Kim S-N, Song SU, Park G, Lee Y-W. Supercritical drying of vascular endothelial growth factor in mesenchymal stem cells culture fluids. J Supercritical Fluids. 2020; 157:104710. doi: 10.1016/j.supflu.2019.104710
- Shen L, Zeng W, Wu Y-X, Hou C-L, Chen W, Yang M-C, et al. Neurotrophin-3 accelerates wound healing in diabetic mice by promoting a paracrine response in mesenchymal stem cells. Cell Transplant. 2013; 22:1011–21.
- Tsyb A, Petrov V, Konoplyannikov A, Saypina E, Lepechina L, Kalsina SS, et al. In vitro inhibitory effect of mesenchymal stem cells on zymosan-induced production of reactive oxygen species. Bull Exp Biol Med. 2008; 146:158–64.
- Pan G, Mu Y, Hou L, Liu J. Examining the therapeutic potential of various stem cell sources for differentiation into insulin-producing cells to treat diabetes. Ann Endocrinol (Paris). 2019; 80:47–53.
- Wan J, Xia L, Liang W, Liu Y, Cai Q. Transplantation of bone marrow-derived mesenchymal stem cells promotes delayed wound healing in diabetic rats. J Diabetes Res. 2013; 2013:647107. doi: 10.1155/2013/647107
- Wang L, Wang F, Zhao L, Yang W, Wan X, Yue C, Mo Z. Mesenchymal stem cells coated by the extracellular matrix promote wound healing in diabetic rats. Stem Cells Int. 2019; 2019:9564869. doi: 10.1155/2019/9564869. [Erratum: doi: 10.1155/2019/9581478]
- Debin L, Youzhao J, Ziwen L, Xiaoyan L, Zhonghui Z, Bing C. Autologous transplantation of bone marrow mesenchymal stem cells on diabetic patients with lower limb ischemia. J Med Colleges PLA. 2008; 23:106–15.
- Jain P, Perakath B, Ranjan Jesudason M, Nayak S. The effect of autologous bone marrow-derived cells on healing chronic lower extremity wounds: results of a randomized controlled study. Ostomy Wound Manage. 2011; 57:38–34.
- Liu Z, Yu D, Xu J, Li X, Wang X, He Z, Zhao T. Human umbilical cord mesenchymal stem cells improve irradiation-induced skin ulcers healing of rat models. Biomed Pharmacother. 2018; 101:729–36.
- Kirana S, Stratmann B, Prante C, Prohaska W, Koerperich H, Lammers D, et al. Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients. Int J Clin Pract. 2012; 66:384–93.
- Lu D, Chen B, Liang Z, Deng W, Jiang Y, Li S, et al. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabetes Res Clin Pract. 2011; 92:26–36.
- Vojtaššák J, Danišovič L, Kubeš M, Bakoš D, Jarabek L, Uličná M, Blaško M. Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot. Neuroendocrinol Lett. 2006; 27(Suppl 2):134–7.
- Wu Q, Lei X, Chen L, Zheng Y, Huang H, Qian C, Liang Z. Autologous platelet-rich gel combined with in vitro amplification of bone marrow mesenchymal stem cell transplantation to treat the diabetic foot ulcer: a case report. Ann Transl Med. 2018; 6:307. doi: 10.21037/atm.2018.07.12
- Li X-Y, Zheng Z-H, Li X-Y, Guo J, Zhang Y, Li H, et al. Treatment of foot disease in patients with type 2 diabetes mellitus using human umbilical cord blood mesenchymal stem cells: response and correction of immunological anomalies. Curr Pharm Des. 2013; 19:4893–9.
- Qin H-L, He K-W, Bin G, Ji Y-L, Huang Y-C, Wang S-Q, et al. Human umbilical cord mesenchymal stem cell transplantation combined with angioplasty for diabetic foot: 3 months angiographic evaluation. Zhongguo Zuzhi Gongcheng Yanjiu [Chinese J Tissue Eng Res]. 2013; 17:2544–51.
- Han S-K, Kim H-R, Kim W-K. The treatment of diabetic foot ulcers with uncultured, processed lipoaspirate cells: a pilot study. Wound Repair Regen. 2010; 18:342–8.
- Lee HC, An SG, Lee HW, Park J-S, Cha KS, Hong TJ, et al. Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: a pilot study. Circ J. 2012; 76:1750–60.
- Masłowski L, Paprocka M, Czyżewska-Buczyńska A, Bielawska-Pohl A, Duś D, Grendziak R, et al. Autotransplantation of the adipose tissue-derived mesenchymal stem cells in therapy of venous stasis ulcers. Arch Immunol Ther Exp (Warsz). 2020; 68:5. doi: 10.1007/s00005-020-00571-9
- Marino G, Moraci M, Armenia E, Orabona C, Sergio R, De Sena G, et al. Therapy with autologous adipose-derived regenerative cells for the care of chronic ulcer of lower limbs in patients with peripheral arterial disease. J Surg Res. 2013; 185:36–44.
- Moon K-C, Suh H-S, Kim K-B, Han S-K, Young K-W, Lee J-W, Kim M-H. Potential of allogeneic adipose-derived stem cell–hydrogel complex for treating diabetic foot ulcers. Diabetes. 2019; 68:837–46.
- Viswanathan C, Shetty P, Sarang S, Cooper K, Ghosh D, Bal A. Role of combination cell therapy in non-healing diabetic ulcers in patients with severe peripheral arterial disease – a preliminary report on five cases. J Diabetic Foot Complications. 2013; 5:1–14.
- Tanaka R, Masuda H, Kato S, Imagawa K, Kanabuchi K, Nakashioya C, et al. Autologous G-CSF-mobilized peripheral blood CD34+ cell therapy for diabetic patients with chronic nonhealing ulcer. Cell Transplant. 2014; 23:167–79.
- Xu SM, Liang T. Clinical observation of the application of autologous peripheral blood stem cell transplantation for the treatment of diabetic foot gangrene. Exp Ther Med. 2016; 11:283–8.
- Stiner R, Alexander M, Liu G, Liao W, Liu Y, Yu J, et al. Transplantation of stem cells from umbilical cord blood as therapy for type I diabetes. Cell Tissue Res. 2019; 378:155–62.
- Lopes L, Setia O, Aurshina A, Liu S, Hu H, Isaji T, et al. Stem cell therapy for diabetic foot ulcers: a review of preclinical and clinical research. Stem Cell Res Ther. 2018; 9:188. doi: 10.1186/s13287-018-0938-6
- Abdal Dayem A, Lee SB, Kim K, Lim KM, Jeon T-I, Seok J, Cho S-G. Production of mesenchymal stem cells through stem cell reprogramming. Int J Mol Sci. 2019; 20:1922. doi: 10.3390/ijms20081922
- Lau T, Lam F, Lau K, Chan Y, Lee K, Sahota D, et al. Pharmacological investigation on the wound healing effects of Radix Rehmanniae in an animal model of diabetic foot ulcer. J Ethnopharmacol. 2009; 123:155–62.
- Watt SM, Gullo F, van der Garde M, Markeson D, Camicia R, Khoo CP, Zwaginga JJ. The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential. Br Med Bull. 2013; 108:25–53.
- Zhao Q-S, Xia N, Zhao N, Li M, Bi C-L, Zhu Q, et al. Localization of human mesenchymal stem cells from umbilical cord blood and their role in repair of diabetic foot ulcers in rats. Int J Biol Sci. 2014; 10:80–9.
- Zhou N, Wang Q-P, Jin X-F, Hou Z-L, Peng B-K, Dan Q-Q, Wang T-H. [Effect of human umbilici mesenchymal stromal cells implantation on the BDNF expression in diabetic foot rats]. Sichuan Da Xue Xue Bao Yi Xue Ban [J Sichuan Univ. Med Sci Edition]. 2013; 44:931–4. [article in Chinese, English Abstract]
- You H-J, Namgoong S, Han S-K, Jeong S-H, Dhong E-S, Kim W-K. Wound-healing potential of human umbilical cord blood–derived mesenchymal stromal cells in vitro—a pilot study. Cytotherapy. 2015; 17:1506–13.
- Qin H-L, He K-W, Gao B, Ji Y-L, Huang Y-C, Wang S-Q, et al. Human umbilical cord mesenchymal stem cell transplantation combined with angioplasty for diabetic foot: 3 months angiographic evaluation. Chinese J Tissue Eng Res. 2013; 17:2544–51.
- Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002; 13:4279–95.
- Wu Q, Chen B, Liang Z. Mesenchymal stem cells as a prospective therapy for the diabetic foot. Stem Cells Int. 2016; 2016:4612167. doi: 10.1155/2016/4612167
- Nambu M, Ishihara M, Kishimoto S, Yanagibayashi S, Yamamoto N, Azuma R, et al. Stimulatory effect of autologous adipose tissue-derived stromal cells in an atelocollagen matrix on wound healing in diabetic db/db mice. J Tissue Eng. 2011; 2011:158105. doi: 10.4061/2011/158105
- Yang M, Sheng L, Zhang TR, Li Q. Stem cell therapy for lower extremity diabetic ulcers: where do we stand? Biomed Res Int. 2013; 2013:462179. doi: 10.1155/2013/462179
- Hassan WU, Greiser U, Wang W. Role of adipose-derived stem cells in wound healing. Wound Repair Regen. 2014; 22:313–25.
- Kim YJ, Kim HK, Cho HH, Bae YC, Suh KT, Jung JS. Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia. Cell Physiol Biochem. 2007; 20:867–76.
- Ikegame Y, Yamashita K, Hayashi S-I, Mizuno H, Tawada M, You F, et al. Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy. 2011; 13:675–85.
- Jiang X-Y, Lu D-B, Chen B. Progress in stem cell therapy for the diabetic foot. Diabetes Res Clin Pract. 2012; 97:43–50.
- Kim S-W, Zhang H-Z, Guo L, Kim J-M, Kim MH. Amniotic mesenchymal stem cells enhance wound healing in diabetic NOD/SCID mice through high angiogenic and engraftment capabilities. PLoS One. 2012; 7:e41105. doi: 10.1371/journal.pone.0041105
- Bura A, Planat-Benard V, Bourin P, Silvestre J-S, Gross F, Grolleau J-L, et al. Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia. Cytotherapy. 2014; 16:245–57.
- Kato Y, Iwata T, Washio K, Yoshida T, Kuroda H, Morikawa S, et al. Creation and transplantation of an adipose-derived stem cell (ASC) sheet in a diabetic wound-healing model. J Vis Exp. 2017:e54539. doi: 10.3791/54539
- Shingyochi Y, Orbay H, Mizuno H. Adipose-derived stem cells for wound repair and regeneration. Expert Opin Biol Ther. 2015; 15:1285–92.
- Ito K, Bonora M, Ito K. Metabolism as master of hematopoietic stem cell fate. Int J Hematol. 2019; 109:18–27.
- Huo Y, Li B-Y, Lin Z-F, Wang W, Jiang X-X, Chen X, et al. MYSM1 is essential for maintaining hematopoietic stem cell (HSC) quiescence and survival. Med Sci Monit. 2018; 24:2541–9.
- Haspel RL, Miller KB. Hematopoietic stem cells: source matters. Curr Stem Cell Res Ther. 2008; 3:229–36.
- Seita J, Weissman IL. Hematopoietic stem cell: self-renewal versus differentiation. Wiley Interdiscip Rev Syst Biol Med. 2010; 2:640–53.
- Hossle JP, Seger RA, Steinhoff D. Gene therapy of hematopoietic stem cells: strategies for improvement. News Physiol Sci. 2002; 17:87–92.
- Kanji S, Das M, Aggarwal R, Lu J, Joseph M, Pompili VJ, Das H. Nanofiber-expanded human umbilical cord blood–derived CD 34+ cell therapy accelerates cutaneous wound closure in NOD/SCID mice. J Cell Mol Med. 2014; 18:685–97.
- Körbling M, Katz RL, Khanna A, Ruifrok AC, Rondon G, Albitar M, et al. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med. 2002; 346:738–46.
- Kirby GTS, Mills SJ, Cowin AJ, Smith LE. Stem cells for cutaneous wound healing. Biomed Res Int. 2015; 2015:285869. doi: 10.1155/2015/285869
- Sietsema WK, Kawamoto A, Takagi H, Losordo DW. Autologous CD34+ cell therapy for ischemic tissue repair. Circ J. 2019; 83:1422–30.
- Barcelos LS, Duplaa C, Kränkel N, Graiani G, Invernici G, Katare R, et al. Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ Res. 2009; 104:1095–102.
- Chotinantakul K, Dechsukhum C, Dejjuy D, Leeanansaksiri W. Enhancement of wound closure in diabetic mice by ex vivo expanded cord blood CD34+ cells. Cell Mol Biol Lett. 2013; 18:263–83.
- Lewis P, Silajdžić E, Brison DR, Kimber SJ. Embryonic stem cells. In: Gimble JM, Marolt Preson D, Oreffo R, Wolbank S, Redl H, editors. Cell engineering and regeneration. Redl H, series editor. Reference Series in Biomedical Engineering. Cham: Springer Nature Switzerland; 2020, p. 315–65.
- Lee KB, Choi J, Cho S-B, Chung J-Y, Moon E-S, Kim N-S, Han H-J. Topical embryonic stem cells enhance wound healing in diabetic rats. J Orthop Res. 2011; 29:1554–62.
- Loretelli C, Nasr MB, Giatsidis G, Bassi R, Lancerotto L, D’Addio F, et al. Embryonic stem cell extracts improve wound healing in diabetic mice. Acta Diabetol. 2020: 57:883–90.
- Lee MJ, Kim J, Lee KI, Shin JM, Chae JI, Chung HM. Enhancement of wound healing by secretory factors of endothelial precursor cells derived from human embryonic stem cells. Cytotherapy. 2011; 13:165–78.
- Clark RAF, Lanigan JM, DellaPelle P, Manseau E, Dvorak HF, Colvin RB. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol. 1982; 79:264–9.
- Mohib K, Allan D, Wang L. Human embryonic stem cell-extracts inhibit the differentiation and function of monocyte-derived dendritic cells. Stem Cell Rev Rep. 2010; 6:611–21.
- Gorecka J, Kostiuk V, Fereydooni A, Gonzalez L, Luo J, Dash B, et al. The potential and limitations of induced pluripotent stem cells to achieve wound healing. Stem Cell Res Ther. 2019; 10:87. doi: 10.1186/s13287-019-1185-1
- Bian X, Ma K, Zhang C, Fu X. Therapeutic angiogenesis using stem cell-derived extracellular vesicles: an emerging approach for treatment of ischemic diseases. Stem Cell Res Ther. 2019; 10:158. doi: 10.1186/s13287-019-1276-z
- Yoshida Y, Yamanaka S. Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell–based regeneration. Circulation. 2010; 122:80–7.
- Singh VK, Kalsan M, Kumar N, Saini A, Chandra R. Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery. Front Cell Dev Biol. 2015; 3:2. doi: 10.3389/fcell.2015.00002
- Baraniak PR, McDevitt TC. Stem cell paracrine actions and tissue regeneration. Regen Med. 2010; 5:121–43.
- Clayton ZE, Tan RP, Miravet MM, Lennartsson K, Cooke JP, Bursill CA, et al. Induced pluripotent stem cell-derived endothelial cells promote angiogenesis and accelerate wound closure in a murine excisional wound healing model. Biosci Rep. 2018; 38:BSR20180563. doi: 10.1042/BSR20180563
- Itoh M, Umegaki-Arao N, Guo Z, Liu L, Higgins CA, Christiano AM. Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs). PLoS One. 2013; 8:e77673. doi: 10.1371/journal.pone.0077673
- Gerami-Naini B, Smith A, Maione AG, Kashpur O, Carpinito G, Veves A, et al. Generation of induced pluripotent stem cells from diabetic foot ulcer fibroblasts using a nonintegrative Sendai virus. Cell Reprogram. 2016; 18:214–23.
- Zheng Y, Ji S, Wu H, Tian S, Zhang Y, Wang L, et al. Topical administration of cryopreserved living micronized amnion accelerates wound healing in diabetic mice by modulating local microenvironment. Biomaterials. 2017; 113:56–67.
- Lv Y, Ge L, Zhao Y. Effect and mechanism of SHED on ulcer wound healing in Sprague-Dawley rat models with diabetic ulcer. Am J Transl Res. 2017; 9:489–98.
- Badillo AT, Redden RA, Zhang L, Doolin EJ, Liechty KW. Treatment of diabetic wounds with fetal murine mesenchymal stromal cells enhances wound closure. Cell Tissue Res. 2007; 329:301–11.
- da Silva LP, Santos TC, Rodrigues DB, Pirraco RP, Cerqueira MT, Reis RL, et al. Stem cell-containing hyaluronic acid-based spongy hydrogels for integrated diabetic wound healing. J Invest Dermatol. 2017; 137:1541–51.
- Kwon DS, Gao X, Liu YB, Dulchavsky DS, Danyluk AL, Bansal M, et al. Treatment with bone marrow-derived stromal cells accelerates wound healing in diabetic rats. Int Wound J. 2008; 5:453–63.
- Ho JH, Tseng T-C, Ma W-H, Ong W-K, Chen Y-F, Chen M-H, et al. Multiple intravenous transplantations of mesenchymal stem cells effectively restore long-term blood glucose homeostasis by hepatic engraftment and β-cell differentiation in streptozocin-induced diabetic mice. Cell Transplant. 2012; 21:997–1009.
- Acosta L, Hmadcha A, Escacena N, Pérez-Camacho I, de la Cuesta A, Ruiz-Salmeron R, et al. Adipose mesenchymal stromal cells isolated from type 2 diabetic patients display reduced fibrinolytic activity. Diabetes. 2013: 62:4266–9.
- Wang Y, Han Z-B, Song Y-P, Han ZC. Safety of mesenchymal stem cells for clinical application. Stem Cells Int. 2012; 2012:652034. doi: 10.1155/2012/652034
- Rubio D, Garcia-Castro J, Martín MC, de la Fuente R, Cigudosa JC, Lloyd AC, et al. Spontaneous human adult stem cell transformation. Cancer Res. 2005; 65:3035–9.
- de la Fuente R, Bernad A, Garcia-Castro J, Martín MC, Cigudosa JC. Retraction: Spontaneous human adult stem cell transformation. Cancer Res. 2010; 70:6682.
- Yang S-S, Kim N-R, Park K-B, Do Y-S, Roh K, Kang K-S, et al. A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease. Int. J Stem Cells. 2013; 6:37–44.
- Qi L, Ahmadi AR, Huang J, Chen M, Pan B, Kuwabara H, et al. Major improvement in wound healing through pharmacologic mobilization of stem cells in severely diabetic rats. Diabetes. 2020; 69:699–712.